Anti-CD19 CAR-T therapy
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Anti-CD19 CAR-T therapy, covering 2018-11-20 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis [Phase 1, Phase 2]